Structural polymorphism in the promoter of pfmrp2 confers Plasmodium falciparum tolerance to quinoline drugs

Drug resistance in Plasmodium falciparum remains a challenge for the malaria eradication programmes around the world. With the emergence of artemisinin resistance, the efficacy of the partner drugs in the artemisinin combination therapies (ACT) that include quinoline-based drugs is becoming critical...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:Mol Microbiol
Main Authors: Mok, Sachel, Liong, Kek-Yee, Lim, Eng-How, Huang, Ximei, Zhu, Lei, Preiser, Peter Rainer, Bozdech, Zbynek
Format: Artigo
Jezik:Inglês
Izdano: BlackWell Publishing Ltd 2014
Teme:
Research Articles
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC4286016/
https://ncbi.nlm.nih.gov/pubmed/24372851
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/mmi.12505
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki